Challenges to Cell Expansion for Allogenic Cell Therapies: Sourcing of donor cells, access to fit-for-purpose reagents and manufacturing systems, and scalability are top issues.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 36; no. 8; pp. 22 - 26
Autor principal: CHALLENER, CYNTHIA A.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Aug2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169801649&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 169801649
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Aug2023
      vid: 36
      iid: 8
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        169801649
        169801649
        169801649
        169801649
      ppf: 22
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Challenges to Cell Expansion for Allogenic Cell Therapies: Sourcing of donor cells, access to fit-for-purpose reagents and manufacturing systems, and scalability are top issues.
      aug:
        au: CHALLENER, CYNTHIA A.
        affil: PhD is a contributing editor to BioPharm International
      sug:
        subj:
          Cell Proliferation
          Allogeneic Cells
          Cell Therapy
          Bone Marrow Transplantation
          Indicators and Reagents
          Killer Cells, Natural
          Cryopreservation
          T Lymphocytes
          Biological Products
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N